CVE-2022-41953
HIGHEPSS 93th pctlDescription
Git GUI is a convenient graphical tool that comes with Git for Windows. Its target audience is users who are uncomfortable with using Git on the command-line. Git GUI has a function to clone repositories. Immediately after the local clone is available, Git GUI will automatically post-process it, among other things running a spell checker called `aspell.exe` if it was found. Git GUI is implemented as a Tcl/Tk script. Due to the unfortunate design of Tcl on Windows, the search path when looking for an executable _always includes the current directory_. Therefore, malicious repositories can ship with an `aspell.exe` in their top-level directory which is executed by Git GUI without giving the user a chance to inspect it first, i.e. running untrusted code. This issue has been addressed in version 2.39.1. Users are advised to upgrade. Users unable to upgrade should avoid using Git GUI for cloning. If that is not a viable option, at least avoid cloning from untrusted sources.
How to fix
Remediation is compiled from vendor and distribution security advisories. Always confirm against the linked source for your exact version and platform.
CVSS v3 Vector
Exploitability
Impact
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
Exploit Intelligence
High risk: more likely to be exploited than 93% of all known CVEs.
References
Embed a live status badge for CVE-2022-41953
Markdown
[](https://tridentstack.com/cve/CVE-2022-41953)HTML
<a href="https://tridentstack.com/cve/CVE-2022-41953"><img src="https://tridentstack.com/cve/badge/CVE-2022-41953.svg" alt="CVE-2022-41953"></a>Find and fix vulnerabilities across your fleet
TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.
Start freeThis product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.